Literature DB >> 28056125

Prognostic Implications of the Largest Basal Tumor Diameter vs the TNM Staging System in Association With the Gene Expression Profile for Uveal Melanoma-Reply.

J William Harbour1.   

Abstract

Entities:  

Year:  2017        PMID： 28056125      PMCID： PMC7849828          DOI： 10.1001/jamaophthalmol.2016.5109

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  6 in total

1.  Outcome prediction and the future of the TNM staging system.

Authors:  Harry B Burke
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

2.  Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Devron H Char; James J Augsburger; Zelia M Correa; Eric Nudleman; Thomas M Aaberg; Michael M Altaweel; David S Bardenstein; Paul T Finger; Brenda L Gallie; George J Harocopos; Peter G Hovland; Hugh D McGowan; Tatyana Milman; Prithvi Mruthyunjaya; E Rand Simpson; Morton E Smith; David J Wilson; William J Wirostko; J William Harbour
Journal:  Ophthalmology       Date:  2012-04-21       Impact factor: 12.079

3.  Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.

Authors:  Zélia M Corrêa; James J Augsburger
Journal:  Am J Ophthalmol       Date:  2015-11-18       Impact factor: 5.258

4.  Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.

Authors:  Scott D Walter; Daniel L Chao; William Feuer; Joyce Schiffman; Devron H Char; J William Harbour
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

5.  Staging of ciliary body and choroidal melanomas based on anatomic extent.

Authors:  Emma Kujala; Bertil Damato; Sarah E Coupland; Laurence Desjardins; Nikolaos E Bechrakis; Jean-Daniel Grange; Tero Kivelä
Journal:  J Clin Oncol       Date:  2013-07-01       Impact factor: 44.544

6.  Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.

Authors:  Matthew G Field; Michael A Durante; Christina L Decatur; Bercin Tarlan; Kristen M Oelschlager; John F Stone; Jeffim Kuznetsov; Anne M Bowcock; Stefan Kurtenbach; J William Harbour
Journal:  Oncotarget       Date:  2016-09-13
  6 in total
  1 in total

1.  Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

Authors:  J William Harbour; Manuel Paez-Escamilla; Louis Cai; Scott D Walter; James J Augsburger; Zelia M Correa
Journal:  Am J Ophthalmol       Date:  2018-09-07       Impact factor: 5.258
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.